133 related articles for article (PubMed ID: 12086824)
1. 2,7-Di-tert-butyl-Fmoc-P-OSu: a new polymer-supported reagent for the protection of the amino group.
Chinchilla R; Dodsworth DJ; Nájera C; Soriano JM
Bioorg Med Chem Lett; 2002 Jul; 12(14):1817-20. PubMed ID: 12086824
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, experimental and in silico studies of N-fluorenylmethoxycarbonyl-O-tert-butyl-N-methyltyrosine, coupled with CSD data: a survey of interactions in the crystal structures of Fmoc-amino acids.
Bojarska J; Remko M; Madura ID; Kaczmarek K; Zabrocki J; Wolf WM
Acta Crystallogr C Struct Chem; 2020 Apr; 76(Pt 4):328-345. PubMed ID: 32229714
[TBL] [Abstract][Full Text] [Related]
3. Fmoc-2-mercaptobenzothiazole, for the introduction of the Fmoc moiety free of side-reactions.
Isidro-Llobet A; Just-Baringo X; Ewenson A; Alvarez M; Albericio F
Biopolymers; 2007; 88(5):733-7. PubMed ID: 17385207
[TBL] [Abstract][Full Text] [Related]
4. A one-pot procedure for the preparation of N-9-fluorenylmethyloxycarbonyl-α-amino diazoketones from α-amino acids.
Siciliano C; De Marco R; Guidi LE; Spinella M; Liguori A
J Org Chem; 2012 Dec; 77(23):10575-82. PubMed ID: 23146162
[TBL] [Abstract][Full Text] [Related]
5. Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.
Perich JW; Reynolds EC
Int J Pept Protein Res; 1991 Jun; 37(6):572-5. PubMed ID: 1717394
[TBL] [Abstract][Full Text] [Related]
6. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
Li S; Whitehead JK; Hammer RP
J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of N-nosyl- and N-Fmoc-N-methyl-alpha-amino acids.
Di Gioia ML; Leggio A; Liguori A; Perri F
J Org Chem; 2007 May; 72(10):3723-8. PubMed ID: 17439178
[TBL] [Abstract][Full Text] [Related]
8. Zinc-promoted simple synthesis of oligomer-free N(alpha)-Fmoc-amino acids using Fmoc-Cl as an acylating agent under neutral conditions.
Gopi HN; Suresh Babu VV
J Pept Res; 2000 Apr; 55(4):295-9. PubMed ID: 10798374
[TBL] [Abstract][Full Text] [Related]
9. An efficient and highly selective deprotection of N-Fmoc-alpha-amino acid and lipophilic N-Fmoc-dipeptide methyl esters with aluminium trichloride and N,N-dimethylaniline.
Di Gioia ML; Leggio A; Le Pera A; Siciliano C; Liguori A; Sindona G
J Pept Res; 2004 Apr; 63(4):383-7. PubMed ID: 15102056
[TBL] [Abstract][Full Text] [Related]
10. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
Meyer JP; Davis P; Lee KB; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1995 Sep; 38(18):3462-8. PubMed ID: 7658433
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase guanidinylation of peptidyl amines compatible with standard Fmoc-chemistry: formation of monosubstituted guanidines.
Bionda N; Cudic P
Methods Mol Biol; 2013; 1081():151-65. PubMed ID: 24014439
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected form.
Qian WJ; Lai CC; Kelley JA; Burke TR
Chem Biodivers; 2014 May; 11(5):784-91. PubMed ID: 24827688
[TBL] [Abstract][Full Text] [Related]
13. Thermal cleavage of the fmoc protection group.
Höck S; Marti R; Riedl R; Simeunovice M
Chimia (Aarau); 2010; 64(3):200-2. PubMed ID: 21140921
[TBL] [Abstract][Full Text] [Related]
14. N-9-fluorenylmethoxycarbonylpyroglutamate. Preparation of the acid, chloride and succinimidyl ester.
Benoiton NL; Chen FM
Int J Pept Protein Res; 1994 Apr; 43(4):321-4. PubMed ID: 8045676
[TBL] [Abstract][Full Text] [Related]
15. Immobilized glycosylated Fmoc-amino acid for SPR: comparative studies of lectin-binding to linear or biantennary diLacNAc structures.
Nakamura K; Sakagami H; Asanuma-Date K; Nagasawa N; Nakahara Y; Akiyama H; Ogawa H
Carbohydr Res; 2013 Dec; 382():77-85. PubMed ID: 24211369
[TBL] [Abstract][Full Text] [Related]
16. Geometrical and conformational preferences of the 9-fluorenylmethoxycarbonyl-amino moiety.
Broda MA; Mazur L; Kozioł AE; Rzeszotarska B
J Pept Sci; 2004 Jul; 10(7):448-61. PubMed ID: 15298180
[TBL] [Abstract][Full Text] [Related]
17. Concise preparation of N(alpha)-Fmoc-N(epsilon)-(Boc, methyl)-lysine and its application in the synthesis of site-specifically lysine monomethylated peptide.
Huang ZP; Du JT; Su XY; Chen YX; Zhao YF; Li YM
Amino Acids; 2007 Jul; 33(1):85-9. PubMed ID: 17031472
[TBL] [Abstract][Full Text] [Related]
18. Investigation on enantiomeric separations of fluorenylmethoxycarbonyl amino acids and peptides by high-performance liquid chromatography using native cyclodextrins as chiral stationary phases.
Tang Y; Zukowski J; Armstrong DW
J Chromatogr A; 1996 Sep; 743(2):261-71. PubMed ID: 8843658
[TBL] [Abstract][Full Text] [Related]
19. Preparation and properties of Nalpha-9-fluorenylmethyloxycarbonylamino acids bearing tert.-butyl side chain protection.
Chang CD; Waki M; Ahmad M; Meienhofer J; Lundell EO; Haug JD
Int J Pept Protein Res; 1980 Jan; 15(1):59-66. PubMed ID: 7358458
[TBL] [Abstract][Full Text] [Related]
20. Addition of carbon-based nucleophiles to Fmoc-protected acyl iminium ions.
Hartman AE; Brophy CL; Cupp JA; Hodge DK; Peelen TJ
J Org Chem; 2009 May; 74(10):3952-4. PubMed ID: 19366203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
